Midatech Pharma PLC | Mutual Funds
Mutual Funds that own Midatech Pharma PLC
CF Woodford Equity Income
12,085,111
19.75%
0
0.06%
07/31/2018
Legal & General UK Alpha Trust
5,587,700
9.13%
0
1.11%
07/31/2018
City Financial Absolute Equity Fund
2,150,000
3.51%
0
0.28%
09/29/2017
Marlborough UK Micro Cap Growth Fund
1,974,604
3.23%
-92,055
0.05%
03/29/2018
Baillie Gifford UK & Balanced Fund - British Smaller Companies
1,283,696
2.1%
0
0.2%
04/30/2018
Oryx International Growth Fund Ltd.
990,000
1.62%
990,000
0.23%
03/31/2017
318,961
0.52%
950
0.01%
07/31/2018
Octopus AIM VCT 2 Plc
147,403
0.24%
-1,336
0.06%
05/31/2017
Hargreave Hale AIM VCT 1 Plc
121,612
0.2%
-2,358
0.05%
09/30/2017
Hargreave Hale AIM VCT 2 Plc
56,341
0.09%
-50,554
0.03%
02/28/2017
| Address |
Oddfellows House
Cardiff Cardiff CF24 0AA
United Kingdom
|
|
Employees
|
- |
| Website |
http://midatechpharma.com/ |
| Updated |
07/08/2019 |
| Midatech Pharma Plc commercializes oncology treatments and cancer supportive care products through its U. S. commercial organization, Midatech Pharma US. |
